Investigation of the mechanical and degradation properties of Mg-Sr and Mg-Zn-Sr alloys for use as potential biodegradable implant materials.

Magnesium (Mg) has garnered significant interest for its potential use as a biodegradable implant material. Of specific interest in this study is the effect of zinc (Zn) and strontium (Sr) additions on both the mechanical and degradation behaviors in Mg due to their established beneficial effect on strength and microstructural grain refinement while being biocompatible. Three binary Mg-x wt% Sr (x=0.5, 1.0, 1.5) alloys and three ternary Mg-x wt%Zn-0.5 wt% Sr (x=2.0, 4.0, 6.0) were studied to evaluate their mechanical and degradation behavior. Mechanical testing was performed at room temperature on solution-treated and peak aged alloys using microhardness and tensile tests. Degradation was studied using immersion tests in Hanks' solution. Results indicate a decrease in grain size and an increase in strength with increasing Sr and Zn content. When considering degradation behavior Mg-0.5 wt%Sr demonstrated the lowest degradation rate among binary alloys. At constant Sr content at 0.5 wt%, the addition of Zn increased the corrosion rate, with the highest rate for the Mg-6.0 wt%Zn-0.5 wt%Sr. The alloys which best optimized both mechanical and degradation behaviors were Mg-2.0 wt%Zn-0.5 wt%Sr and Mg-4.0 wt%Zn-0.5 wt%Sr. Finally, microstructure and property relationships were evaluated and discussed in reference to each alloy's potential use as a biodegradable implant material.

[1]  P. Marie Strontium ranelate: a novel mode of action optimizing bone formation and resorption , 2004, Osteoporosis International.

[2]  Andrew Taylor,et al.  9 Therapeutic uses of trace elements , 1985 .

[3]  P. Fraker,et al.  Zinc: health effects and research priorities for the 1990s. , 1994, Environmental health perspectives.

[4]  W. Ding,et al.  Effect of strontium on the microstructure, mechanical properties, and fracture behavior of AZ31 magnesium alloy , 2006 .

[5]  Alexis M Pietak,et al.  Magnesium and its alloys as orthopedic biomaterials: a review. , 2006, Biomaterials.

[6]  S. Segura-Muñoz,et al.  Aluminum as a risk factor for Alzheimer's disease. , 2008, Revista latino-americana de enfermagem.

[7]  A. L. Greer,et al.  Modelling of inoculation of metallic melts : Application to grain refinement of aluminium by Al-Ti-B , 2000 .

[8]  M. Störmer,et al.  Biodegradable magnesium-hydroxyapatite metal matrix composites. , 2007, Biomaterials.

[9]  Y. Estrin,et al.  Bio-corrosion of a magnesium alloy with different processing histories , 2008 .

[10]  Michele V. Manuel,et al.  Magnesium: An essential nutrient for a good biomaterial , 2011 .

[11]  K. Hono,et al.  Precipitation-hardenable Mg–2.4Zn–0.1Ag–0.1Ca–0.16Zr (at.%) wrought magnesium alloy , 2009 .

[12]  Yasuzo Tanaka,et al.  The Main Factors Affecting the Aging of Magnesium-Zinc Alloys , 1971 .

[13]  P. Uggowitzer,et al.  MgZnCa glasses without clinically observable hydrogen evolution for biodegradable implants. , 2009, Nature materials.

[14]  J. Buha Reduced temperature (22–100 °C) ageing of an Mg–Zn alloy , 2008 .

[15]  Yufeng Zheng,et al.  Research activities of biomedical magnesium alloys in China , 2011 .

[16]  M. Leeflang,et al.  In vitro degradation behavior and cytocompatibility of Mg–Zn–Zr alloys , 2010, Journal of materials science. Materials in medicine.

[17]  Ke Yang,et al.  In vivo evaluation of biodegradable magnesium alloy bone implant in the first 6 months implantation. , 2009, Journal of biomedical materials research. Part A.

[18]  Frank Witte,et al.  Degradable biomaterials based on magnesium corrosion , 2008 .

[19]  Guohua Wu,et al.  The effect of Ca and rare earth elements on the microstructure, mechanical properties and corrosion behavior of AZ91D , 2005 .

[20]  H. Haferkamp,et al.  In vivo corrosion of four magnesium alloys and the associated bone response. , 2005, Biomaterials.

[21]  Guang-Ling Song,et al.  Control of biodegradation of biocompatable magnesium alloys , 2007 .

[22]  Frank Witte,et al.  In vitro and in vivo corrosion measurements of magnesium alloys. , 2006, Biomaterials.

[23]  Yang Song,et al.  Electrodeposition of Ca-P coatings on biodegradable Mg alloy: in vitro biomineralization behavior. , 2010, Acta biomaterialia.

[24]  N. Birbilis,et al.  Effect of Grain Size on Corrosion: A Review , 2010 .

[25]  J. B. Clark Transmission electron microscopy study of age hardening in a Mg-5 wt.% Zn alloy , 1965 .

[26]  M. Sarntinoranont,et al.  Magnesium as a biodegradable and bioabsorbable material for medical implants , 2009 .

[27]  G. Song,et al.  Corrosion mechanisms of magnesium alloys , 1999 .

[28]  Richard P. Gangloff,et al.  Effect of artificial aging on the fatigue crack propagation resistance of 2000 series aluminum alloys , 2001 .

[29]  Edward Ghali,et al.  Magnesium and Magnesium Alloys , 2011 .

[30]  Ke Yang,et al.  In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application. , 2007, Journal of biomedical materials research. Part A.

[31]  Frank Witte,et al.  The history of biodegradable magnesium implants: a review. , 2010, Acta biomaterialia.

[32]  Yang Song,et al.  Research on an Mg-Zn alloy as a degradable biomaterial. , 2010, Acta biomaterialia.

[33]  Yufeng Zheng,et al.  The development of binary Mg-Ca alloys for use as biodegradable materials within bone. , 2008, Biomaterials.

[34]  C. Christiansen,et al.  Incorporation and distribution of strontium in bone. , 2001, Bone.

[35]  M. Sarntinoranont,et al.  Design considerations for developing biodegradable and bioabsorbable magnesium implants , 2011 .

[36]  Chenglong Liu,et al.  Corrosion behavior of biomedical AZ91 magnesium alloy in simulated body fluids , 2007 .

[37]  L. Wagner,et al.  The relation between severe plastic deformation microstructure and corrosion behavior of AZ31 magnesium alloy , 2009 .

[38]  Jiang Chang,et al.  Effects of strontium in modified biomaterials. , 2011, Acta biomaterialia.

[39]  S. Virtanen,et al.  Time-dependent electrochemical characterization of the corrosion of a magnesium rare-earth alloy in simulated body fluids. , 2008, Journal of biomedical materials research. Part A.

[40]  J. Canales,et al.  Aluminium impairs the glutamate-nitric oxide-cGMP pathway in cultured neurons and in rat brain in vivo: molecular mechanisms and implications for neuropathology. , 2001, Journal of inorganic biochemistry.

[41]  D. StJohn,et al.  A model of grain refinement incorporating alloy constitution and potency of heterogeneous nucleant particles , 2001 .

[42]  D. StJohn,et al.  An analysis of the relationship between grain size, solute content, and the potency and number density of nucleant particles , 2005 .

[43]  J. Nie,et al.  Characterization of strengthening precipitate phases in a Mg–Zn alloy , 2007 .

[44]  S. Kalkura,et al.  Fibrous growth of strontium substituted hydroxyapatite and its drug release , 2011 .

[45]  Yufeng Zheng,et al.  In vitro corrosion and biocompatibility of binary magnesium alloys. , 2009, Biomaterials.

[46]  B. Mordike,et al.  Magnesium: Properties — applications — potential , 2001 .

[47]  E. Merian Metal toxicity in mammals: Edited by D. Luckey and B. Venugopal , 1980 .

[48]  A. K. Dahle,et al.  The role of solute in grain refinement of magnesium , 2000 .

[49]  Andrej Atrens,et al.  Recent Insights into the Mechanism of Magnesium Corrosion and Research Suggestions , 2007 .

[50]  M. Mabuchi,et al.  Review Processing and mechanical properties of fine-grained magnesium alloys , 1999 .

[51]  E. Han,et al.  Electrodeposition of hydroxyapatite coating on AZ91D magnesium alloy for biomaterial application , 2008 .

[52]  M. Medraj,et al.  Thermodynamic assessment of the Mg–Zn–Sr system , 2007 .

[53]  R. Raman,et al.  In vitro degradation and mechanical integrity of calcium-containing magnesium alloys in modified-simulated body fluid. , 2008, Biomaterials.